Deerfield Management Company, L.P. (Series C) Evolus, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $1.95 Million - $2.76 Million	250,000 Added 7.53%	3,569,000 $30.2 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $13.5 Million - $18.5 Million	-2,071,103 Reduced 38.42%	3,319,000 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $13.6 Million - $24.1 Million	1,757,352 Added 48.38%	5,390,103 $43.4 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $24.6 Million - $33.5 Million	2,403,517 Added 195.53%	3,632,751 $42.1 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $6.42 Million - $14.5 Million	1,229,234 New	1,229,234 $13.8 Million

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

Perceptive Advisors LLC New York, NY

5.36M
Shares

$58.1 Million
2.27% of portfolio
Tang Capital Management LLC San Diego, CA

4.85M
Shares

$52.5 Million
6.69% of portfolio
Black Rock Inc. New York, NY

4.01M
Shares

$43.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.2M
Shares

$34.6 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.82M
Shares

$30.6 Million
2.72% of portfolio

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account